InsidersTradesSigma
Track the 达安基因 stock price and the full management transaction log of the company, a listed issuer based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 达安基因 has recorded 1 public disclosures. Market capitalisation: €7.5bn. The latest transaction was disclosed on 20 December 2021 (Sale). Among the most active insiders: 周新宇. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
达安基因 is a company focused on the research and development of molecular diagnostic products. It specializes in genetic testing and public health solutions.